SEC Form 4 · accession 0000899243-17-014270
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
May 22, 2017
Accepted (ET)
May 24, 2017 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.94 | May 22, 2017 | A | 30,000 | A | — | May 22, 2017 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The stock option will vest in four equal quarterly installments on each of June 30, 2017, September 30, 2017, December 31, 2017 and March 31, 2018, subject to the Reporting Person's continued service as a director.